טוען...
Novel Immunotherapeutic Approaches in Head and Neck Cancer
Unresectable recurrent or metastatic head and neck cancer is an incurable disease with survival of approximately 12 months. Head and neck tumors exhibit numerous derangements in the tumor microenvironment that aid in immune evasion and may serve as targets for future therapies. Pembrolizumab is now...
שמור ב:
| הוצא לאור ב: | J Cancer Metastasis Treat |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357897/ https://ncbi.nlm.nih.gov/pubmed/32661502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/2394-4722.2019.32 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|